Letter on ‘Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart Transplantation’
- 27 February 2019
- journal article
- letter
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 21 (6) , 818
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart TransplantationEuropean Journal of Heart Failure, 2018
- Idarucizumab for Dabigatran Reversal — Full Cohort AnalysisNew England Journal of Medicine, 2017
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With WarfarinCirculation, 2012